Ex-vivo expanded effector cells (Dartmouth-Hitchcock Medical Center)

N/A

Report date: 2022/11/20 14:17:07

Base Information

Drug NameEx-vivo expanded effector cells (Dartmouth-Hitchcock Medical Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Cytotoxic T-lymphocytes therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsBone Marrow NeoplasmsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDartmouth-Hitchcock Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesDartmouth-Hitchcock Medical Center
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsBone Marrow Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A